Preswitch Regimens Influence the Rate of Weight Gain After Switch to Tenofovir Disoproxil Fumarate, Lamivudine, and Dolutegravir (TLD): Study From an East African Cohort.
Journal Information
Full Title: Open Forum Infect Dis
Abbreviation: Open Forum Infect Dis
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Potential conflicts of interest. K.B. received research funding from Gilead Sciences and served on advisory boards for Gilead Sciences and Theratechnologies. All other authors report no potential conflicts. S.K.G. has received grant support from the National Institutes of Health and ViiV Healthcare and has participated in data safetymonitoring boards or advisory boards for Gilead Sciences and ViiV Healthcare."
Funding Disclosure
Evidence found in paper:
"Financial support. This study was supported by the Gilead Research Scholars and National Institutes of Health Award Number U01AI069911. Financial support ."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025